There is not yet a consensus on the reliability of the methods that should
be used for the detection of rare disseminated tumor cells from non-hematol
ogical malignancies. In this review, we will discuss the advantage and draw
backs of the classical approach of immunocytochemistry and the molecular de
tection by reverse transcriptase polymerase chain reaction (RT-PCR). The in
terpretation of the biological significance of circulating tumor cells and
the pitfalls of the detection techniques are the main causes of discrepancy
between the conclusions of different tumor-cell detection (TCD) studies.